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gions of the 5# and 3#UTR of CTN-RNA and should not
target mCAT2 mRNA. Thus, the authors conclude that
CTN-RNA is necessary for the stability of mCAT2
mRNA. To delineate which region is required for sta-
bility, they introduce constructs that express different
parts of CTN-RNA and find that loss of mCAT2 mRNA
is rescued by expression of the common 3#UTR se-
quence. The authors propose that when CTN-RNA is
present at normal levels, it sequesters a factor that pro-
motes degradation of mCAT2 mRNA. When CTN-RNA
levels are reduced by the antisense oligonucleotides,
the factor is free to bind to mCAT2 mRNA and promote
its degradation. But if the sequences in CTN-RNA that
bind and sequester the factor are the same as those in
mCAT2 mRNA, why is CTN-RNA not degraded as well?
The antisense data are the most perplexing data in
the Spector paper. In addition, their biological rele-
vance is questionable because it is unclear when CTN-
RNA would naturally be absent—and if it is, why would
mCAT2 mRNA need to be degraded? With a bow to
parsimony, it seems possible that the antisense effect
does not signal an additional complexity in CTN-RNA
regulation but occurs because it mimics what normally
takes place during stress. For example, extending the
posttranscriptional-cleavage/polyadenylation model,
loss of CTN-RNA after antisense treatment might allow
the factor that blocks its proximal polyadenylation site
to act on the mCAT2 mRNA instead, making the latter
unstable. This model does not explain why the mCAT2
mRNA cannot use the distal polyadenylation site when
proximal polyadenylation is blocked, but a possibility is
that the use of the distal site is promoter dependent.
The observation that CTN-RNA is cleaved and moves
to the cytoplasm in response to stress is the most sig-
nificant observation in the Spector paper, and one with
far-reaching implications. If this is a general mecha-
nism, it implies that nuclear retention, perhaps medi-
ated by inverted repeats containing inosine, serves to
store translatable RNAs for their release as needed.
Thus, the data hint at an explanation for the existence
of the mysterious repeats in hnRNA and suggest an an-
swer to a conundrum in the ADAR field—if inosines pro-
mote nuclear retention, how are the scores of ADAR
substrates translated (Levanon et al., 2004; Morse et
al., 2002)? If the fate of CTN-RNA is a general one, the
answer is that cleavage releases the inosine-containing
part of the 3#UTR.
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Hereditary Spastic Paraplegia:
Respiratory Choke
or Unactivated Substrate?
Defects in the mitochondrial AAA protease family
member, paraplegin, result in an autosomal recessive
form of hereditary spastic paraplegia (HSP). In this
issue of Cell, Nolden et al. (2005) report a new molec-
ular mechanism for HSP based on the requirement of
paraplegin for the proteolysis of a specific mitochon-
drial ribosomal protein. The processing of this sub-
strate is required for robust translation in mito-
chondria.
Hereditary spastic paraplegia (HSP) is a genetically het-
erogenous neurodegenerative disease affecting one in
10,000 people. HSP is characterized by progressive
weakness and spasticity of the lower limbs due to de-
generation of corticospinal axons, the longest axons in
the human body. Twenty genetic loci have been linked
with various forms of HSP that collectively display the
spectrum of inheritance patterns from autosomal domi-
nant and recessive to X-linked. Defects in mitochon-
drial function have been associated with two types of
HSP. In this issue of Cell, Nolden, Langer, and col-
leagues (2005) provide a new molecular mechanism for
HSP, associated with a mutation in the gene encoding
paraplegin resulting in the absence of proteolytic pro-
cessing of a ribosomal protein in mitochondria.
The genetic locus (SPG13) associated with the au-
tosomal dominant form of HSP has been linked to a
mutation in the mitochondrial matrix chaperonin Hsp60
(Hansen et al., 2002). Hsp60 is part of a multimeric
complex that mediates the folding and assembly of im-
ported proteins in mitochondria. Mutant Hsp60 may as-
semble into the chaperonin complex and poison its
ability to fold and assemble newly imported substrates
(see Figure 1B). As a result, the accumulation of mis-
folded polypeptides may cause the pathology of HSP.
The gene mutated in an autosomal recessive form of
HSP, SPG7, encodes a protein highly homologous to
the AAA family of mitochondrial proteases (Casari et
al., 1998). The protein product of the SPG7 gene, para-
plegin, is localized to the mitochondrial inner mem-
brane (see Figure 1). In patients with this mutation,
studies have revealed a deficiency in respiratory com-
plex I and an increased sensitivity to oxidative stress
(Atorino et al., 2003). Moreover, a mouse deficient in
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mouse exhibits abnormal mitochondria that accumu-
late at distal regions of axons before the onset of de-
tectable axonal swelling and degeneration, but coinci-
dent with the initiation of measurable motor defects
(Ferreirinha et al., 2004).
What is the molecular basis for HSP caused by the
loss of paraplegin? Paraplegin is a subunit of a member
of the mitochondrial AAA (ATPases associated with a
number of cellular activities) protease family primarily
characterized in budding yeast, Saccharomyces cere-
visiae. The assembly of the respiratory chain complexes
in the mitochondrial inner membrane depends on the
coordinated expression and oligomerization of nuclear
and mitochondrial encoded subunits. A unique quality
control system is present to ensure that these com-
plexes assemble properly and that unassembled sub-
units do not accumulate and potentially “choke” cellu-
lar respiration. The key components of this quality
control system are two evolutionarily conserved, mem-
brane bound AAA proteases, the i-AAA protease and
the m-AAA protease (Arnold and Langer, 2002). The
m-AAA protease is a heterooligomer of undefined stoi-
chiometry consisting of Yta10 and Yta12 subunits in
yeast and Afg3L2 and paraplegin in mouse and man.
The subunits of these AAA proteases are highly con-
served between yeast and humans. In fact, the human
counterparts of the yeast proteins complement the ob-
served-growth phenotypes associated with the corre-
sponding yeast deletion strains (Atorino et al., 2003;
Shah et al., 2000).
The principal functions of the yeast m-AAA protease
are 2-fold. The first function is to degrade unassembled
respiratory subunits, which requires the proteolytic ac-
tivity of both subunits of the multimer. The second is to
assist in the folding of respiratory complexes III, IV, and
V, which requires that only one of the two subunits has
an active proteolytic site (Arlt et al., 1998, 1996). Thus,
one potential explanation for the progressive nature of
HSP could be the accumulation of unassembled respi-
ratory subunits in the mitochondrial inner membrane
(see Figure 1B), similar to the effect proposed for a loss
of Hsp60 function.
However, two observations contradict this hypothe-
sis. First, protein aggregates have not been detected
upon inactivation of AAA proteases. Second, the ability
of yeast to grow on respiratory substrates requires that
only one of the two m-AAA protease subunits contain
an active proteolytic site, even though degradation of
unassembled substrates requires that both subunits be
proteolytically active. Hence, the accumulation of unas-
sembled inner-membrane proteins may not account for
the pathology of HSP associated with mutations in
paraplegin.
Another potential explanation for the observed phe-
notypes associated with paraplegin loss of function in
yeast, mouse, and humans is that m-AAA proteolysis is
required for the function of a protein and, in the ab-
sence of paraplegin, the activity of this protein is lost
(see Figure 1A). Are there proteins that require proteoly-
sis mediated by m-AAA proteases for their activity? In
this issue of Cell, Nolden et al. (2005) address this
question by identifying specific substrates of the yeast
m-AAA protease. To do this, they used an elegant strat-
F
P
t
(
t
m
(
t
(
m
o
c
v
o
(
(
t
i
T
i
e
Y
a
t
s
n
(
M
a
c
m
p
a
p
c
m
tgy in which they expressed versions of Yta10 and
ta12 lacking protease activity (one of which carried an
ffinity tag) in the yta10/yta12 yeast mutants. Impor-
antly, previous work by the Langer group had demon-
trated that these “protease-dead” subunits assemble
ormally and retain the ability to bind to their substrates
Arlt et al., 1998). Through this approach, they identified
rpL32, a component of the large ribosomal subunit,
s a substrate of yeast m-AAA protease. MrpL32 is en-
oded by nuclear DNA and the protein is imported into
itochondria. Import of MrpL32 is accompanied by a
rocessing step that is catalyzed by the m-AAA prote-
se. Interestingly, processing of MrpL32 by the m-AAA
rotease only requires one of the two subunits to be
atalytically active suggesting that MrpL32 maturation
ight correlate with respiratory competence. The au-
hors demonstrate that this is the case.igure 1. Two Potential Mechanisms that Contribute to HSP
olypeptide chains that are synthesized in the cell cytoplasm are
hreaded through pores (TOM and TIM) in the outer membrane
OM) and inner membrane (IM) of mitochondria. These polypep-
ides (green and orange) then fold correctly in the mitochondrial
atrix with the help of chaperonins, such as the Hsp60 complex
red and yellow) and m-AAA protease (blue and purple). Proteins
hat are incorrectly folded are degraded by proteases.
A) In the model described by Nolden et al. (2005), inactivation of
-AAA protease (composed of paraplegin and Afg3L2), due to loss
f paraplegin function (light purple), results in the inability to pro-
ess protease substrates, such as MrpL32 (green), preventing acti-
ation of these substrates. In the absence of proteolytic activation
f MrpL32, mitochondrial translation is drastically impaired.
B) Alternatively, mutations in paraplegin (light purple), Hsp60
pink), or other candidate genes associated with HSP may result in
he accumulation of unfolded or misfolded peptides resulting in the
mproper assembly of respiratory chain complexes (dark blue).
OM, translocase of the outer membrane; TIM, translocase of the
nner membrane; IMS, intermembrane space.
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185What is the function of MrpL32 and do all of its activi-
ties require m-AAA proteolysis? Nolden et al. (2005)
show that mitochondrial translation is diminished to a
similar extent in the absence of either MrpL32 or a
functional m-AAA protease. This indicates that the
m-AAA protease is likely to control mitochondrial trans-
lation through processing of MrpL32 (Nolden et al.,
2005), although this conclusion was not formally dem-
onstrated. The reason for the drastic impact on mito-
chondrial translation is unclear. Processing of MrpL32
by the m-AAA protease results in a very tight associa-
tion of MrpL32 with the mitochondrial inner membrane,
even though no transmembrane domains are predicted.
The association of MrpL32 with the inner membrane
might serve to localize active ribosomes to the mem-
brane, which may be important for efficient translation.
Not all of the functions of MrpL32 require that it be pro-
cessed given that large ribosomes still assemble with-
out unprocessed MrpL32, in mitochondria with de-
fective m-AAA protease. In contrast, in the absence of
MrpL32, ribosomes, both large and small, fail to assem-
ble. This implies that the incorporation of mature
MrpL32 into the large ribosome is critical for translation
in mitochondria. Alternatively, processed MrpL32 may
exist in a complex independent of the large ribosome
but still essential for mitochondrial translation. This lat-
ter possibility is supported by the observation that pro-
cessed MrpL32 only partially comigrates with large ri-
bosomal subunits in sucrose gradients.
Finally, Nolden et al. (2005) demonstrate the conser-
vation of MrpL32 processing by showing that the
mousem-AAA protease can process yeast MrpL32 and
vice versa. Moreover, in liver mitochondria from mouse
cells lacking paraplegin, an apparently unprocessed
form of MrpL32 accumulates, although processed
MrpL32 is readily detected. The fact that there is some
processing of MrpL32 in mitochondria lacking para-
plegin clearly indicates that in both mice and humans,
there may exist unidentified AAA-protease subunits
that can pair with Afg3L2 and partially replace para-
plegin or other unrelated proteases, absent in yeast,
compensating for loss of paraplegin. Strikingly, the in-
complete processing of mouse MrpL32 in mitochondria
lacking paraplegin correlates with a decrease in mito-
chondrial translation. However, it must be pointed out
that a similar experiment using muscle biopsies ob-
tained from HSP patients harboring a deleted para-
plegin gene failed to reveal any defect in mitochondrial
translation (Atorino et al., 2003).
In the end, the lack of processing of MrpL32 by
m-AAA protease may not be the critical event that
causes the pathology of HSP. Instead, what the work
reported by Nolden et al. (2005) reveals is the possibility
of a more general pathogenic mechanism involving the
absence of proteolytic activation of additional sub-
strates of the m-AAA protease, which may account for
HSP. This mechanism does not mutually exclude the
involvement of an accumulation of nonassembled pro-
teins in the mitochondrial inner membrane. In fact, one
could argue that such proteins may act to clog com-
pensatory proteases, effectively competing with sub-
strates that require proteolysis for their activity. The
critical question that still remains is why is it specifically
the neurons with the longest axons that are affected bythe mutation of a mitochondrial protein with an appar-
ent housekeeping function? The revelation by Nolden
et al. (2005) of a new mechanism for HSP associated
with a defect in paraplegin should aid in the resolution
of this fundamental question.
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